Back to search

Article

Nrf2 overexpression increases risk of high tumor mutation burden in acute myeloid leukemia through inhibiting MSH2

2020-09-01

Abstract excerpt

<h4>Background: </h4> Nuclear factor erythroid 2-related factor 2 (Nrf2, also called NFE2L2) has been shown to play a pivotal role in preventing cancer cells from being affected by chemotherapy. Gene mutation is a crucial reason of chemotherapy-resistance in acute myeloid leukemia (AML). However, the relationship between Nrf2 and tumor mutation burden and its mechanism in regulating chemotherapy-resistance remains...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6b5ecc3c-cd1e-556a-be55-ab08addb6c94
DOI
10.21203/rs.3.rs-66229/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Nrf2 overexpression increases risk of high tumor mutation burden in acute myeloid leukemia through inhibiting MSH2DOI 10.21203/rs.3.rs-66229/v1
Select a neighboring publication to make it the new centre.